Red Spruce Capital, LLC Abbott Laboratories Transaction History

Red Spruce Capital, LLC

$212 Million
Q3 2024

A detailed history of Red Spruce Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Red Spruce Capital, LLC holds 33,293 shares of ABT stock, worth $3.9 Million. This represents 1.79% of its overall portfolio holdings.

Number of Shares

33,293

Previous 32,715 1.77%

Holding current value

$3.9 Million

Previous $3.4 Million 11.65%

% of portfolio

1.79%

Previous 1.63%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$100.07 - $118.13 $57,840 - $68,279	578 Added 1.77%	33,293 $3.8 Million
Q2 2024 Jul 02, 2024	BUY	$100.73 - $112.44 $132,057 - $147,408	1,311 Added 4.17%	32,715 $3.4 Million
Q1 2024 Apr 10, 2024	BUY	$109.52 - $120.96 $261,533 - $288,852	2,388 Added 8.23%	31,404 $3.57 Million
Q4 2023 Jan 05, 2024	BUY	$90.19 - $110.4 $343,804 - $420,844	3,812 Added 15.12%	29,016 $3.19 Million
Q3 2023 Oct 03, 2023	BUY	$95.53 - $114.62 $3,916 - $4,699	41 Added 0.16%	25,204 $2.44 Million
Q2 2023 Jul 05, 2023	BUY	$100.78 - $112.29 $22,675 - $25,265	225 Added 0.9%	25,163 $2.74 Million
Q1 2023 Apr 06, 2023	BUY	$96.86 - $114.01 $137,831 - $162,236	1,423 Added 6.05%	24,938 $2.53 Million
Q4 2022 Jan 03, 2023	BUY	$95.06 - $111.52 $73,291 - $85,981	771 Added 3.39%	23,515 $0
Q3 2022 Oct 03, 2022	BUY	$96.76 - $112.03 $88,438 - $102,395	914 Added 4.19%	22,744 $2.2 Million
Q2 2022 Jul 05, 2022	SELL	$102.07 - $123.37 $10,002 - $12,090	-98 Reduced 0.45%	21,830 $2.37 Million
Q1 2022 Apr 05, 2022	BUY	$114.02 - $139.04 $93,838 - $114,429	823 Added 3.9%	21,928 $2.6 Million
Q4 2021 Jan 03, 2022	BUY	$115.53 - $141.46 $19,871 - $24,331	172 Added 0.82%	21,105 $2.97 Million
Q3 2021 Oct 04, 2021	BUY	$116.66 - $129.06 $47,597 - $52,656	408 Added 1.99%	20,933 $2.47 Million
Q2 2021 Jul 06, 2021	BUY	$105.79 - $124.53 $37,978 - $44,706	359 Added 1.78%	20,525 $2.38 Million
Q1 2021 Apr 01, 2021	BUY	$108.84 - $128.23 $65,739 - $77,450	604 Added 3.09%	20,166 $2.42 Million
Q4 2020 Jan 04, 2021	SELL	$105.0 - $114.42 $194,355 - $211,791	-1,851 Reduced 8.64%	19,562 $2.14 Million
Q3 2020 Oct 02, 2020	SELL	$91.64 - $111.29 $3,207 - $3,895	-35 Reduced 0.16%	21,413 $2.33 Million
Q2 2020 Jul 02, 2020	BUY	$76.57 - $98.0 $18,606 - $23,814	243 Added 1.15%	21,448 $1.96 Million
Q1 2020 Apr 06, 2020	SELL	$62.82 - $91.86 $2,010 - $2,939	-32 Reduced 0.15%	21,205 $1.67 Million
Q4 2019 Jan 16, 2020	BUY	$78.51 - $87.4 $1.67 Million - $1.86 Million	21,237 New	21,237 $1.85 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.

Account

Red Spruce Capital, LLC Abbott Laboratories Transaction History